Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

GP CPCS referral commences amid hopes service will be highly valued by patients and GPs alike

Following a period of successful piloting, the NHS Community Pharmacist Consultation Service (CPCS) has, from Nov 1, been extended to include referrals from general practices in addition to NHS 111.

General practices now can choose to refer patients to the CPCS for minor illnesses, but the Pharmaceutical Pharmaceutical Services Negotiating Committee says there must be local discussions to agree how this will work before GPs able able to make these referrals.


"These discussions will involve pharmacy contractors, the primary care network (PCN) and the member general practices, the NHS and your local pharmaceutical committee (LPC)," the pharmacy negotiator adds in its update to community pharmacy.

Commenting on the official start of the new referral system, Alastair Buxton, director of NHS Services at PSNC said: “The rollout of this new referral pathway will be gradually achieved over the next few months; this is deliberately not a big bang start. However, the official commencement is still a noteworthy event, as we expect this addition to the CPCS to become a community pharmacy service offering which is highly valued by patients and general practice alike.

“The successful rollout of this service will rely on team working, with NHSE&I regional teams providing local leadership and support, with assistance from others, including LPCs.

“The NHS has a significant task to undertake in supporting general practices to engage with the CPCS. Discussions between community pharmacy and general practice within PCNs will also be critical to achieving a successful local rollout.

“In some cases this may be the first time the two professions have had such discussions, but while there may be challenges to overcome, this referral pathway should create a new foundation of collaboration between general practices and pharmacies, which can be built on in the years ahead.”

Pharmacies which are already registered to provide CPCS do not need to re-register to receive referrals from GPs, as this is an extension to the existing advanced services.

However, contractors who are not registered to provide the service will need to register via the NHSBSA Manage Your Service (MYS) portal to be allowed to run the advanced service.

The CPCS was launched by the NHS on October 29 last year as a means to integrate community pharmacy into local urgent care services, providing more convenient treatment closer to patients’ homes.

The first phase of the service offered patients the option of having a face-to-face or remote consultation with a pharmacist following an initial assessment by an NHS 111 call advisor.

More For You

RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less
Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less
Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less